1,985
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Should network biology be used for drug discovery?

&
Pages 1135-1137 | Received 12 Jul 2016, Accepted 12 Sep 2016, Published online: 23 Sep 2016

References

  • Paul SM, Mytelka DS, Dunwiddie CT, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9:203–214. DOI:10.1038/nrd3078
  • Scannell JW, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11:191–200. DOI:10.1038/nrd3681
  • Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960–1964.
  • Chen B, Butte AJ. Leveraging big data to transform target selection and drug discovery. Clin Pharmacol Ther. 2016;99:285–297.
  • Chou KC. Impacts of bioinformatics to medicinal chemistry. Med Chem. 2015;11:218–234.
  • Sliwoski G, Kothiwale S, Meiler J, et al. Computational methods in drug discovery. Pharmacol Rev. 2014;66:334–395.
  • Hutchinson L, Kirk R. High drug attrition rates – where are we going wrong? Nat Rev Clin Oncol. 2011;8:189–190.
  • Lindsay MA. Target discovery. Nat Rev Drug Discov. 2003;2:831–838.
  • Wang YC, Chen BS. A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. BMC Med Genomics. 2011;4:2.
  • Csermely P, Korcsmaros T, Kiss HJ, et al. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther. 2013;138:333–408. DOI:10.1016/j.pharmthera.2013.01.016
  • Wang X, Thijssen B, Yu H. Target essentiality and centrality characterize drug side effects. PLoS Comput Biol. 2013;9:e1003119. DOI:10.1371/journal.pcbi.1003119
  • Arkin MR, Tang Y, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol. 2014;21:1102–1114. DOI:10.1016/j.chembiol.2014.09.001
  • Scott DE, Bayly AR, Abell C, et al. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov. 2016;15:533–550. DOI:10.1038/nrd.2016.29
  • Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682–690. Epub 2008/10/22. DOI:10.1038/nchembio.118
  • Bansal M, Yang J, Karan C, et al. A community computational challenge to predict the activity of pairs of compounds. Nat Biotechnol. 2014;32:1213–1222. DOI:10.1038/nbt.3052
  • Hughes JP, Rees S, Kalindjian SB, et al. Principles of early drug discovery. Br J Pharmacol. 2011;162:1239–1249. DOI:10.1111/j.1476-5381.2010.01127.x
  • Bento AP, Gaulton A, Hersey A, et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42:D1083–90. DOI:10.1093/nar/gkt1031
  • Wang Y, Suzek T, Zhang J, et al. PubChem bioassay: 2014 update. Nucleic Acids Res. 2014;42:D1075–82. DOI:10.1093/nar/gkt978.
  • Gonzalez-Diaz H, Herrera-Ibata DM, Duardo-Sanchez A, et al. ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks. J Chem Inf Model. 2014;54:744–755. DOI:10.1021/ci400716y.
  • Campillos M, Kuhn M, Gavin AC, et al. Drug target identification using side-effect similarity. Science. 2008;321:263–266. DOI:10.1126/science.1158140
  • Cheng F, Liu C, Jiang J, et al. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol. 2012;8:e1002503. DOI:10.1371/journal.pcbi.1002503
  • Yamanishi Y, Kotera M, Moriya Y, et al. DINIES: drug-target interaction network inference engine based on supervised analysis. Nucleic Acids Res. 2014;42:W39–45. DOI:10.1093/nar/gku337
  • Woo JH, Shimoni Y, Yang WS, et al. Elucidating compound mechanism of action by network perturbation analysis. Cell. 2015;162:441–451.
  • Duran-Frigola M, Rossell D, Aloy P. A chemo-centric view of human health and disease. Nat Commun. 2014;5:5676.
  • Kalinina OV, Wichmann O, Apic G, et al. ProtChemSI: a network of protein-chemical structural interactions. Nucleic Acids Res. 2012;40:D549–D553. Epub 2011/11/24.
  • Martinez-Jimenez F, Marti-Renom MA. Ligand-target prediction by structural network biology using nAnnoLyze. PLoS Comput Biol. 2015;11:e1004157.
  • González-Díaz, H. ADMET-Multi-Output Cheminformatics Models for Drug Delivery, Interactomics, and Nanotoxicology. Current Drug Delivery. 2016;13:1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.